Ventura's permanent interatrial shunt was designed to shunt blood from the left to right atrium to improve symptoms in patients with advanced chronic heart failure. The hourglass-shaped, nitinol-frame ...

An FDA advisory panel unanimously agreed that Johnson & Johnson MedTech's V-Wave Ventura interatrial shunt's risks outweigh ...

J&J is pursuing premarket approval for the heart shunt. Although advisory committees provide recommendations to the FDA, the ...

The outside advisors analyzed the results of the RELIEVE-HF pivotal trial, which randomized 508 patients to either receive ...

Panelists considered the technology relatively safe but weren’t swayed by the “statistical gymnastics” needed to find a ...

An FDA advisory panel gave a unanimous verdict for an interatrial shunt in heart failure: no way.

The FDA’s Circulatory System Devices Panel voted not to recommend approving use of an interatrial shunt to improve heart failure symptoms and prognosis.In a 0-15 vote, the committee determined risk ...

Current. Too little of it, and you can’t get where you’re going, too much and your hardware’s on fire. In many projects, it’s desirable to know just how much current is being drawn, and even more ...

Background. Little is known regarding the optimal treatment of ventriculoperitoneal (VP) shunt infections in adults. Our aim was to assess the efficacy of treatment strategies and to identify factors ...

At just 19, what seemed like common exam anxiety turned a harrowing corner when a catastrophic collapse unveiled a brain ...